International Journal of Radiation Oncology Biology Physics

Article	Citations
The R's of Radiation Therapy: Do We Need More or Do We Move On?	189
If Medicine were my Spouse	134
In Regard to Langé et al	113
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine	108
Surgical Status in the Era of New Molecular Diagnostics: Insights from a Single-Center Case Series Report in China	101
Quantifying the Effect of 4-Dimensional Computed Tomography–Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated wi	92
Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy	90
Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma	83
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey	81
Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review	78
Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma	76
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database	76
Molecular Changes in Breast Cancer Induced by Radiation Therapy	71
Prospective and Comprehensive Characterization of an Inpatient Radiation Oncology Consult Service: Examining Interdisciplinary Coordination of Palliative Radiation Access and Receipt	69
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization	67
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy	67
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer	66
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis	65
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors	62
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma	58
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria	57
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	57
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma	56
Trends in Private Equity Involvement in Oncology Practices in the United States	54
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation	54

Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	54
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases	52
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning	51
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	50
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial	50
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy	49
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	49
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	49
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)	49
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy	49
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients	48
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies	47
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer	46
Issue Highlights page	46
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy	46
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy	46
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys	45
Withdrawn	45
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma	45
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	44
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain	44
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial	44
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St	44
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors	43
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	42
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial	42
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	42
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	42
Withdrawn	42
Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas	41
Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade	41
Intraoral Gavage of Second-Generation Probiotic Lactobacillus Reuteri Releasing IFN-β (LR-IFN-β) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiation (WAI)	41
Is a Deep Learning Based Segmentation Model Trained on planning CTs Transferable for Segmentation of Organs at Risk in Replanning CTs?	41
Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	41
Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and Evaluation	41
In Reply to Takiar and Beadle	40
Stereotactic Body Radiation Therapy for Large Volume Solid Tumor Spinal Metastases Involving Three or More Contiguous Vertebral Levels	39
The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study	38
Withdrawn	37
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	37
Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results	36
Withdrawn	36
Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis	36
Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema	36
A Randomized Controlled Phase Ⅱ Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer	36
Evaluating Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) Treatment Effect on Neurocognitive Function (NCF): Secondary Analysis of NRG-CC001	35
Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients wi	35
Rays Over Knife	35
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	34
Maximization of Peak-to-Valley Dose Ratio and Normal-Tissue Survival Fraction for Proton Minibeam Radiation Therapy	34

Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule	34
The Dutch Initiative for the Model-Based Selection of Patients for Proton Therapy – A Federated Learning IT Infrastructure	33
Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy	33
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	33
Financial Toxicity in Patients with Gynecologic Cancer Undergoing Brachytherapy	33
Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy	33
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	32
Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India	32
Issue Highlights page	32
Validation of Lexicographic Optimization-Based Planning for Brain Metastases Radiosurgery with Coplanar Arcs	32
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	32
Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia after Radiotherapy in Breast Cancer	32
IL-1β+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal Effect	32
A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer	32
Initial Experience with the Commercial Electron FLASH Research Extension	32
DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring Guidelines	32
Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	32
Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial	32
Less Is More: A Hypofractionated Approach	32
In Regard to Hammer et al.	32
Arytenoid-Sparing Intensity-Modulated Radiotherapy for Early-Stage Glottic Cancer	31
Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imagin	31
Incidence of Flap Failure Following Sinonasal Surgery, Flap Reconstruction and Postoperative Proton Radiation Therapy	31
Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors	30
Contralateral Nodal Relapse (CLNR) in Well Lateralized Oral Cavity Cancer Treated Ipsilaterally with Surgery and Adjuvant Radiotherapy with or without Concurrent Chemotherapy: A Retrospective Audit	30
Vertex Position Optimization for LATTICE Therapy	30
HyperArc Planning for Benign Intracranial Pathologies: A Prospective Analysis on Plan Quality, Delivery, Control and Toxicity	30
The Effect of Package Time on Locally Advanced Oral Cavity Cancer Outcomes	30
Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma Patients	30
Hyperfractionated and Accelerated Reirradiation for Angiosarcoma Following Breast-Conserving Therapy: Long-Term Clinical Outcomes	30
Balancing Quality and Efficiency of Head and Neck Contour Revision for Online Adaptive Radiotherapy	30
Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?	29
The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer	29
Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy	29
A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation Damage	29
Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate Marker	29
Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation	29
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	29
Rapid Reinstatement of Cancer Care after Hurricane Ian	28
Prospective Evaluation of Locoregional Control in Oral Cavity Squamous Cell Carcinoma with Infratemporal Fossa Involvement Treated with Surgery and Adjuvant Concurrent Chemoradiotherapy	28
Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy	28
Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy	28
Irradiation Dose to the Swallowing Muscles Impacts Nutritional Status in Head and Neck Cancer Patients: The Prospective Randomized HEADNUT Trial	28
A Novel Multi-Channel Tandem Applicator for Direction Modulated Brachytherapy	28
Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax	28
A Radiation Therapy Contouring Atlas for Delineation of the Level I-II Axilla in the Prone Position	28
Clinical Outcomes in cN+M0 Bladder Cancer Patients: Can Bladder be Spared?	28
Geometric and Dosimetric Evaluation of Using a Novel Tongue Positioning Device to Reduce Tongue Motions during Radiation Therapy for Head and Neck Cancer	27
Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large Tumor	27
Interprofessional Teaming: Is a One-hour Novel Didactic/Interactive Leadership Class Feasible?	27
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody	27
Artificial Intelligence Auto Contouring and its Impact on Resident Education	27
Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer Radiotherapy	27
Withdrawn	27
Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy	27
Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer	27
KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses	27
Accelerated Partial Breast Irradiation (APBI) Using Five Daily Fractions: A Prospective, Phase II, Multi-Center Trial of Cosmetic Outcomes and Toxicity: Final Results	27
Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103	27
Atypical Nodal Involvement From an Atypical Meningioma	27
Issue Highlights page	27
Performance of Multiparametric MRI and PET Imaging in Identifying and Localizing Locally Radiorecurrent Prostate Cancer in a Phase I/II Trial of Focal Salvage HDR	27
Local Therapy for Oligometastatic Disease—Cart Before the Horse?	27
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT Data	27
Stereotactic Ablative Radiotherapy for the Treatment of Pancreatic Metastases from Renal Cell Carcinoma	26
Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?	26
TEAching Mentoring in Radiation Oncology (TEAMRO): a ROECSG GME multi-institutional pilot study on teaching mentorship skills to residents	26
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study	26
In Reply to Onal et al	26
The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies	26
Doing Our Best With What We Have (and Know)	26
Expression of concern to “The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer” Liu et al, Int J Radiat Oncol Biol Phys, 2019;104(5):1153-1164.	25
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)	25
Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical Trial	25
Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy	25
1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 Fractions	25
Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy	25
Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics	24
Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer	24
Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins	24

Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis	24
Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA	24
The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study	24
A Simple Method to Generate Descriptive Images for Recurrent Cervix Cancer Using Predictive ResNet Model Weights and Feature Maps	24
Clinical Outcomes of Patients with Early-Stage Breast Cancer Treated with Five-Fraction Partial Breast Irradiation vs. Intraoperative Radiation Therapy	24
Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases	23
Personalized Minimal Residual Disease Profiling Predicts Prognosis in Esophageal Carcinoma Undergoing Definitive Radiotherapy	23
Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution	23
Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety	23
Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety	23
Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy	23
Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy	23
Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative	23
Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients	23
The Association of Genetic Polymorphisms in the TNF-α Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy	23
Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy	23
Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics	23
Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation	23
Withdrawn	23
Optimizing Radiation Treatment for Glioblastoma Patients: Contrasting Dosimetric Profiles of HyperArc and Volumetric Arc Therapy	23
Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy	23
Identification of Triapine as a Novel Radiosensitizer in Glioblastoma	23
Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy	23
Impact of Deep Learning Auto Segmentation Accuracy on Duodenal Dose-Volume Parameters for Pancreas SBRT Patients Treated with MR-Guided Online Adaptive Radiotherapy	23
Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity	22
Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis	22
Phase I/II Prospective Dose Escalation Trial with Proton-Based Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base and Cervical Spine: Long-Term Results from Proton Radiation Oncolog	22
Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy	22
A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression	22
Multi-Omics Sequencing Unveils Tumor Microenvironment Remodeling Induced by Combined Radiotherapy and Immunotherapy in Microsatellite-Stable Locally Advanced Rectal Cancer	22
Spatiotemporal Fractionation Schemes and Additional OAR Sparing for Single-Beam-per-Fraction FLASH-RT Using Transmission Proton Beam	22
Prostate CAncer Integrated Risk Evaluation (P-CARE): A Model to Stratify Risk of Any, Metastatic, and Fatal Prostate	22
Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction	22
Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	22
Assessing Dose Uncertainties in Cardiac SBRT due to Cardiorespiratory Motion: Photon vs. Proton Therapy Comparison	22
Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer	22
Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy	22
Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center	22
Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma	22
Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)	22
Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience	22
Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network	22
Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort	22
Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy	22
Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Program's Impact	22
Deep Dive into the Performance of the 5D Breathing Motion Model	22
A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup	22
Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion	21
Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapy's Environmental Load?	21
A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	21
Feasibility of an Online MR-Guided Scan-Plan-Treat Workflow for Emergency Palliation	21
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers	21
Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant	21
A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy	21
Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study	21
“Big Jolts Like an Electric Shock:” Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer	21
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021	21
A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes	21
Re-Irradiation in Children with Recurrent Medulloblastoma	21
Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion—An ASTRO SCAROP-ADROP-ARRO Collaboration	20
Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by 18F-FAPI PET/CT	20
Efficacy and Safety of All-Site Radiation Therapy and Standard of Care Therapy with or without Docetaxel for Hormone-Sensitive High Gleason Score Prostate Cancer: 6-Year Results from a Long-Term Study	20
Low Dose Radiation Therapy (LDRT) for Osteoarthritis: A Retrospective Study of 59 Patients and 94 Joints Treated	20
Pivotal Roles of Tumor-Draining Lymph Nodes in the Abscopal Effect from Combined Immunotherapy and Radiotherapy	20
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC	20
A Phase 2 Multi-Center, Placebo-Controlled, Randomized Study to Assess the Safety and Efficacy of Parenteral TK-90 for Preventing Radiation-Induced Mucositis in Patients with Squamous Cell Carcinoma o	20
Postoperative Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer With GammaPod Technology: A Phase 2 Clinical Trial	20
Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?	20
The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation	20
Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations	20
Clinical Outcomes and Safety of the Combination of External Beam Radiotherapy with 177Lu-DOTATATE	20
Caught Between a Radiation Oncology Case Rate (ROCR) and a Hard Place: Improving Proposed Radiation Oncology Alternative Payment Models	20
A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Red	20
Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study	20
Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer	20
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer	20
Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial	20
EPIC-26 Longitudinal Analyses of Prostatic Urethral Lift Implant with Stereotactic Ablative Body Radiotherapy for Men with Prostate Cancer and Benign Prostatic Hyperplasia	20
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic Review	20
In Reply to Hannoun-Levi et al	20
Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy	20
Can Generative AI Agents Match the Experts? Measuring Large Language Model Performance in Evaluating NSCLC Treatment Plans	19
Evaluating Outcomes of Patients Receiving SRS to More Than 15 Brain Metastases in a 12-Month Span	19
Assessment of Subventricular Zone Irradiation in Glioblastoma Patients	19
Clinical Factors Associated with Urinary Morbidity in Men Undergoing Combination Prostate Radiation Therapy	19
Postmarketing Surveillance of Adverse Events after Immune Checkpoint Inhibitor Therapy and Radiotherapy	19
Prophylactic Cranial Irradiation in Resected Early Stage Small Cell Lung Cancer: An Updated Systematic Review and Meta-Analysis	19
Does the Addition of Chemotherapy to Adjuvant Radiation Benefit the Survival for Patients with Adenocarcinoma of Cervix after Radical Surgery? A Single-Center Retrospective Cohort Study	19
Analysis of the Safety Cohort of a Phase II Study of Preoperative Stereotactic Radiosurgery for Brain Metastases	19
Neoadjuvant Immunotherapy Followed by Response-Adapted Definitive Radiotherapy for Unresectable, Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Dosimetric Analysis of a Phase	19
MR-Linac-Based Adaptive and Non-Adaptive SBRT for Prostate and Pancreatic Cancer vs. Conventional-Linac-Based Treatment: A Time-Driven Activity-Based Costing Analysis	19
Reconstruction Complications after Adjuvant Radiotherapy for Patients with Skin Cancer	19
Comparative Analysis of Lymph Node-Only vs. Bone-Only Metastasis-Directed Radiation Therapy in Oligorecurrent Prostate Cancer	19
Exploring the Efficacy and Optimal Duration of Tumor Treating Fields (TTFields) in Newly Diagnosed Who Grade 4 Gliomas: A Multi-Institutional Analysis	19
The Dosimetric Feasibility of Lattice Radiotherapy for Cervical Cancer with a Novel X - Ray and γ - Ray Combined Approach	19